原肌球蛋白受体激酶B
trk受体
神经营养因子
神经营养素
癌症研究
医学
头颈部鳞状细胞癌
脑源性神经营养因子
转移
原肌球蛋白受体激酶A
表皮生长因子受体
受体酪氨酸激酶
内科学
肿瘤科
放射治疗
受体
头颈部癌
癌症
作者
Juliana Kern de Moraes,Vivian Petersen Wagner,Felipe Paiva Fonseca,Pablo Agustín Vargas,Caroline Brunetto de Farias,Rafael Roesler,Manoela Domingues Martins
摘要
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family of growth factors that was first known as responsible for sustain the growth, function, and plasticity of neural cells. BDNF exerts its effects by binding to the tyrosine kinase receptor B (TrkB). The BDNF/TrkB axis has been reported to be overexpressed in several neurogenic and non-neurogenic tumors. Its higher expression was associated with a poor prognosis to patients affected by different human malignancies, tumor growth, invasion, and metastasis; epithelial-mesenchymal transition and resistance to chemotherapy. BDNF/TrkB represent promising targets to the development of novel anticancer therapies. Some clinical trials are currently evaluating the efficacy of Trk protein-target drugs in different types of solid tumors. To date, few groups have evaluated the DNF/TrkB pathway in head and neck malignancies. The aims of this study were to review the literature concerning the role of BDNF/TrkB activation in head and neck squamous cell carcinoma and malignant salivary gland tumors and to discuss future perspectives of BDNF/TrkB-target therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI